Outbreak spotlights safety of custom-mixed drugs

October 4, 2012 by Marilynn Marchione

Custom-mixed medicines like the steroid shots suspected in a meningitis outbreak have long been a source of concern, and their use is far wider than many people realize.

These medicines are made in private and hospital pharmacies and used to treat everything from cancer to menopause symptoms to .

Often these products are name-brand medicines split into smaller doses, or mixed from ingredients sold in bulk. That can easily lead to contamination if aren't maintained. The germ suspected in the current outbreak can spread in the air.

A shortage of many drugs has forced doctors to stretch supplies and seek custom-made alternatives if the first-choice treatment was not available.

The meningitis outbreak has killed four and sickened at least two dozen in five states.

Explore further: Rare US fungal meningitis outbreak grows; 5 dead (Update)

shares

Related Stories

Rare US fungal meningitis outbreak grows; 5 dead (Update)

October 3, 2012
(AP)—A fifth person has died in a growing outbreak of a rare form of meningitis that has sickened more than two dozen people in five U.S. states.

10 people die of suspected Ebola in Congo

August 22, 2012
(AP) — The World Health Organization says an outbreak of suspected Ebola in eastern Congo has infected at least 15 people, 10 of whom died.

Rare US fungal meningitis outbreak grows; 5 dead (Update)

October 4, 2012
(AP)—A fifth person has died in a growing outbreak of a rare form of meningitis that has sickened more than two dozen people in five U.S. states.

Sierra Leone says cholera killed 66 since January

July 21, 2012
(AP) — Sierra Leone's health ministry says a cholera outbreak has sickened more than 3,800 and killed 66 people since January.

Recommended for you

Drug for spinal muscular atrophy prompts ethical dilemmas, bioethicists say

December 11, 2017
When the Food and Drug Administration approved the first drug for people with spinal muscular atrophy a year ago, clinicians finally had hope for improving the lives of patients with the rare debilitating muscular disease. ...

FDA's program to speed up drug approval shaved nearly a year off the process

December 7, 2017
Speeding the pace at which potentially lifesaving drugs are brought to market was a rallying cry for Donald Trump as a candidate, and is a stated priority of his Food and Drug Administration commissioner, Dr. Scott Gottlieb. ...

Dangers of commonly prescribed painkillers highlighted in study

December 6, 2017
Commonly prescribed painkillers need to be given for shorter periods of time to reduce the risk of obesity and sleep deprivation, a new study has revealed.

Viagra goes generic: Pfizer to launch own little white pill

December 6, 2017
The little blue pill that's helped millions of men in the bedroom is turning white. Drugmaker Pfizer is launching its own cheaper generic version of Viagra rather than lose most sales when the impotence pill gets its first ...

Surgery-related opioid doses can drop dramatically without affecting patients' pain

December 6, 2017
Some surgeons might be able to prescribe a third of opioid painkiller pills that they currently give patients, and not affect their level of post-surgery pain control, a new study suggests.

Four-fold jump in deaths in opioid-driven hospitalizations

December 4, 2017
People who end up in the hospital due to an opioid-related condition are four times more likely to die now than they were in 2000, according to research led by Harvard Medical School and published in the December issue of ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.